Federal contractor profile
THE MCLEAN HOSPITAL CORPORATION
UEI MCKWJYCWNVN3CAGE 1F6D4
Active
Overview
- Legal name
- THE MCLEAN HOSPITAL CORPORATION
- Registered location
- BELMONT, MA, USA
- Primary NAICS
- 622210 — Psychiatric and Substance Abuse Hospitals
- Latest award activity
- Jul 24, 2026
Read company summary
THE MCLEAN HOSPITAL CORPORATION is associated with UEI MCKWJYCWNVN3 and CAGE 1F6D4 in public federal records. AcornBids currently links 9 prime awards totaling $32.7M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology); Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); Medical Laboratories. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 622210 (Psychiatric and Substance Abuse Hospitals). Its public SAM.gov registration lists BELMONT, MA, USA.
At a glance
Lifetime prime obligations$32.7M
Prime awards9
Awards with future end dates3
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- THE MCLEAN HOSPITAL CORPORATION
- UEI
- MCKWJYCWNVN3
- CAGE
- 1F6D4
- Registered address
- 115 MILL ST, BELMONT, MA, 02478, USA
- Registration status
- Active
- Primary NAICS
- 622210 — Psychiatric and Substance Abuse Hospitals
- SAM activation
- Mar 24, 2026
- Initial registration
- Feb 4, 2002
- Entity start
- Jul 25, 1979
- SAM updated
- Mar 24, 2026
- Registration expires
- Mar 20, 2027
- Fiscal year end
- Sep 30
- Place of incorporation
- MA, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 15DDHQ26F00000692DOE, MCLEAN HOSPITAL, DEPRESSANTS | Department of Justice | $144.5K | Sep 1, 2026 | Aug 31, 2027 |
| 15DDHQ24A000000082024-0090 THIS REQUEST IS TO CREATE A BPA FOR THE PROJECT AS DESCRIBED BELOW. MCLEAN HOSPITAL HAS BEEN SELECTED AS THE VENDOR. DC/DR HAS MANDATED REGULATORY FUNCTION TO MONITOR… | Department of Justice | $1.1M | May 1, 2024 | Not available |
| 15DDHQ26F00000576DOE, MCLEAN HOSPITAL, BENZODIAZEPINE TESTING | Department of Justice | $134.3K | Jul 14, 2026 | Jul 13, 2027 |
| 15DDHQ24F00000794TITLE: DOE, MCLEAN HOSPITAL, BENZODIAZEPINE TESTING REQUESTOR: CASSANDRA PRIOLEAU REF AWARD/BPA: 15DDHQ23Q00000149 POP DATES: 07/18/2024 TO 07/17/2025 DELIVERY DATE: 07/18/2024 | Department of Justice | $114.4K | Aug 16, 2024 | Aug 15, 2025 |
| 75N95026C00003THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY (NBB)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE… | Department of Health and Human Services | $3.6M | Nov 1, 2025 | Oct 31, 2030 |
| 75N95019C00007IGF::OT::IGF ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2019. BASE AWARD. | Department of Health and Human Services | $6.2M | Dec 13, 2018 | Dec 15, 2023 |
| 75N95024C00004ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. | Department of Health and Human Services | $2.7M | Dec 16, 2023 | Dec 15, 2025 |
| 15DDHQ25F00000600DOE, MCLEAN HOSPITAL, BENZODIAZEPINE TESTING | Department of Justice | $141.5K | Jul 14, 2025 | Jul 13, 2026 |
| 75N95019C00046NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORYCONTRACT TYPE: COST, OPTIONPERIOD OF PERFORMANCE: 09/01/2019 TO 08/31/2020 | Department of Health and Human Services | $19.7M | Sep 1, 2019 | Oct 31, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Mar 24, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Feb 4, 2002 |
| Entity start | Jul 25, 1979 |
| Industry | Reported size status |
|---|---|
| 541380 — Testing Laboratories and Services | Not reported |
| 621511 — Medical Laboratories | Not reported |
| 622210 — Psychiatric and Substance Abuse Hospitals | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| ROBERT MORRISON | Government business | Contact method not published | SAM registration | Not available |
| RAQUEL ESPINOSA | Alternate government business | Contact method not published | SAM registration | Not available |
| ROBERT MORRISON | Electronic business | Contact method not published | SAM registration | Not available |
| KELLEY MCCUE | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541380 — Testing Laboratories and Services
- 621511 — Medical Laboratories
- 622210 — Psychiatric and Substance Abuse Hospitals
Registered products and services
- AN22 — HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; APPLIED RESEARCH
- AN32 — HEALTH R&D SERVICES; CONSUMER AND OCCUPATIONAL HEALTH AND SAFETY; APPLIED RESEARCH
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
70 awards
53 awards
36 awards
34 awards
30 awards
About THE MCLEAN HOSPITAL CORPORATION
What products and services appear in its federal awards?
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology); 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); 621511 — Medical Laboratories.
Recorded products and services: AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH; Q301 — Reference Laboratory Testing.
Examples from recent award records:
- DOE, MCLEAN HOSPITAL, DEPRESSANTS
- 2024-0090 THIS REQUEST IS TO CREATE A BPA FOR THE PROJECT AS DESCRIBED BELOW. MCLEAN HOSPITAL HAS BEEN SELECTED AS THE VENDOR. DC/DR HAS MANDATED REGULATORY FUNCTION TO MONITOR…
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
115 MILL ST, BELMONT, Massachusetts 02478, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
622210 — Psychiatric and Substance Abuse Hospitals.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services; Department of Justice.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit